These data suggest that decreased levels of IL-6 following antipsychotic therapy could be predisposing factor for the development of obesity and obesity-related metabolic disorders in schizophrenia (Figure 1). The gene discussed is IL6; the disease is obesity due to melanocortin 4 receptor deficiency.